Pharmaceutical composition for treating diabetes

Pharmaceutical composition for treating diabetes

The invention relates to the technical field of diabetes treatment, in particular to a pharmaceutical composition for treating diabetes, which comprises 2 parts of ginseng, 2 parts of astragalus membranaceus, 2 parts of radix rehmanniae recen, 2 parts of radix scrophulariae, 2 parts of medlar, 1 par...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: LIANG YONGLIN, LI QIN, BAI MIN, ZHAO YIKUN, ZHAI YANHUI, LIU RONG, LIU MENGYA, GAO YANKUI, AN DONG, LI XIAOLING
Format: Patent
Sprache:chi ; eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator LIANG YONGLIN
LI QIN
BAI MIN
ZHAO YIKUN
ZHAI YANHUI
LIU RONG
LIU MENGYA
GAO YANKUI
AN DONG
LI XIAOLING
description The invention relates to the technical field of diabetes treatment, in particular to a pharmaceutical composition for treating diabetes, which comprises 2 parts of ginseng, 2 parts of astragalus membranaceus, 2 parts of radix rehmanniae recen, 2 parts of radix scrophulariae, 2 parts of medlar, 1 part of cortex lycii radicis, 1 part of kudzu vine root, 1 part of coptis chinensis, 1 part of white mulberry root-bark, 1 part of mulberry, 1 part of rhizoma atractylodis, 3 parts of paulownia fruit, 3 parts of turmeric root and 3 parts of green coffee bean. The pharmaceutical composition has the beneficial effects that pharmacological and toxicological experiments prove that in a mouse diabetes model, the hypoglycemic effect of the pharmaceutical composition is superior to that of a reference drug metformin, the pharmaceutical composition is good in administration safety, no toxic reaction occurs under the test dosage 20 times of the normal administration dosage, and in addition, the pharmaceutical composition has g
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116440236A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116440236A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116440236A3</originalsourceid><addsrcrecordid>eNrjZDAIyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMz1NIyy9SKClKTSzJzEtXSMlMTEotSS3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQVAo_JSS-Kd_QwNzUxMDIyMzRyNiVEDAJ9JK8o</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Pharmaceutical composition for treating diabetes</title><source>esp@cenet</source><creator>LIANG YONGLIN ; LI QIN ; BAI MIN ; ZHAO YIKUN ; ZHAI YANHUI ; LIU RONG ; LIU MENGYA ; GAO YANKUI ; AN DONG ; LI XIAOLING</creator><creatorcontrib>LIANG YONGLIN ; LI QIN ; BAI MIN ; ZHAO YIKUN ; ZHAI YANHUI ; LIU RONG ; LIU MENGYA ; GAO YANKUI ; AN DONG ; LI XIAOLING</creatorcontrib><description>The invention relates to the technical field of diabetes treatment, in particular to a pharmaceutical composition for treating diabetes, which comprises 2 parts of ginseng, 2 parts of astragalus membranaceus, 2 parts of radix rehmanniae recen, 2 parts of radix scrophulariae, 2 parts of medlar, 1 part of cortex lycii radicis, 1 part of kudzu vine root, 1 part of coptis chinensis, 1 part of white mulberry root-bark, 1 part of mulberry, 1 part of rhizoma atractylodis, 3 parts of paulownia fruit, 3 parts of turmeric root and 3 parts of green coffee bean. The pharmaceutical composition has the beneficial effects that pharmacological and toxicological experiments prove that in a mouse diabetes model, the hypoglycemic effect of the pharmaceutical composition is superior to that of a reference drug metformin, the pharmaceutical composition is good in administration safety, no toxic reaction occurs under the test dosage 20 times of the normal administration dosage, and in addition, the pharmaceutical composition has g</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230718&amp;DB=EPODOC&amp;CC=CN&amp;NR=116440236A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230718&amp;DB=EPODOC&amp;CC=CN&amp;NR=116440236A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LIANG YONGLIN</creatorcontrib><creatorcontrib>LI QIN</creatorcontrib><creatorcontrib>BAI MIN</creatorcontrib><creatorcontrib>ZHAO YIKUN</creatorcontrib><creatorcontrib>ZHAI YANHUI</creatorcontrib><creatorcontrib>LIU RONG</creatorcontrib><creatorcontrib>LIU MENGYA</creatorcontrib><creatorcontrib>GAO YANKUI</creatorcontrib><creatorcontrib>AN DONG</creatorcontrib><creatorcontrib>LI XIAOLING</creatorcontrib><title>Pharmaceutical composition for treating diabetes</title><description>The invention relates to the technical field of diabetes treatment, in particular to a pharmaceutical composition for treating diabetes, which comprises 2 parts of ginseng, 2 parts of astragalus membranaceus, 2 parts of radix rehmanniae recen, 2 parts of radix scrophulariae, 2 parts of medlar, 1 part of cortex lycii radicis, 1 part of kudzu vine root, 1 part of coptis chinensis, 1 part of white mulberry root-bark, 1 part of mulberry, 1 part of rhizoma atractylodis, 3 parts of paulownia fruit, 3 parts of turmeric root and 3 parts of green coffee bean. The pharmaceutical composition has the beneficial effects that pharmacological and toxicological experiments prove that in a mouse diabetes model, the hypoglycemic effect of the pharmaceutical composition is superior to that of a reference drug metformin, the pharmaceutical composition is good in administration safety, no toxic reaction occurs under the test dosage 20 times of the normal administration dosage, and in addition, the pharmaceutical composition has g</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAIyEgsyk1MTi0tyUxOzFFIzs8tyC_OLMnMz1NIyy9SKClKTSzJzEtXSMlMTEotSS3mYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQVAo_JSS-Kd_QwNzUxMDIyMzRyNiVEDAJ9JK8o</recordid><startdate>20230718</startdate><enddate>20230718</enddate><creator>LIANG YONGLIN</creator><creator>LI QIN</creator><creator>BAI MIN</creator><creator>ZHAO YIKUN</creator><creator>ZHAI YANHUI</creator><creator>LIU RONG</creator><creator>LIU MENGYA</creator><creator>GAO YANKUI</creator><creator>AN DONG</creator><creator>LI XIAOLING</creator><scope>EVB</scope></search><sort><creationdate>20230718</creationdate><title>Pharmaceutical composition for treating diabetes</title><author>LIANG YONGLIN ; LI QIN ; BAI MIN ; ZHAO YIKUN ; ZHAI YANHUI ; LIU RONG ; LIU MENGYA ; GAO YANKUI ; AN DONG ; LI XIAOLING</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116440236A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>LIANG YONGLIN</creatorcontrib><creatorcontrib>LI QIN</creatorcontrib><creatorcontrib>BAI MIN</creatorcontrib><creatorcontrib>ZHAO YIKUN</creatorcontrib><creatorcontrib>ZHAI YANHUI</creatorcontrib><creatorcontrib>LIU RONG</creatorcontrib><creatorcontrib>LIU MENGYA</creatorcontrib><creatorcontrib>GAO YANKUI</creatorcontrib><creatorcontrib>AN DONG</creatorcontrib><creatorcontrib>LI XIAOLING</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LIANG YONGLIN</au><au>LI QIN</au><au>BAI MIN</au><au>ZHAO YIKUN</au><au>ZHAI YANHUI</au><au>LIU RONG</au><au>LIU MENGYA</au><au>GAO YANKUI</au><au>AN DONG</au><au>LI XIAOLING</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Pharmaceutical composition for treating diabetes</title><date>2023-07-18</date><risdate>2023</risdate><abstract>The invention relates to the technical field of diabetes treatment, in particular to a pharmaceutical composition for treating diabetes, which comprises 2 parts of ginseng, 2 parts of astragalus membranaceus, 2 parts of radix rehmanniae recen, 2 parts of radix scrophulariae, 2 parts of medlar, 1 part of cortex lycii radicis, 1 part of kudzu vine root, 1 part of coptis chinensis, 1 part of white mulberry root-bark, 1 part of mulberry, 1 part of rhizoma atractylodis, 3 parts of paulownia fruit, 3 parts of turmeric root and 3 parts of green coffee bean. The pharmaceutical composition has the beneficial effects that pharmacological and toxicological experiments prove that in a mouse diabetes model, the hypoglycemic effect of the pharmaceutical composition is superior to that of a reference drug metformin, the pharmaceutical composition is good in administration safety, no toxic reaction occurs under the test dosage 20 times of the normal administration dosage, and in addition, the pharmaceutical composition has g</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language chi ; eng
recordid cdi_epo_espacenet_CN116440236A
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Pharmaceutical composition for treating diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T23%3A09%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LIANG%20YONGLIN&rft.date=2023-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116440236A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true